Hexone glucokinase inhibitor and use thereof
PH12021551635B1Active Publication Date: 2026-11-06SHANDONG XUANZHU PHARMA TECH CO LTD +1
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12021551635
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-07-06
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2041-07-06
Abstract
The present invention relates to the technical field of pharmaceuticals, and in particular to a ketohexokinase inhibitor compound, a pharmaceutically acceptable salt, an ester or a stereoisomer thereof; a pharmaceutical composition and formulation containing the compound, the pharmaceutically acceptable salt, the ester or the stereoisomer thereof; a method for preparing the compound, the pharmaceutically acceptable salt, the ester or the stereoisomer thereof; and use of the compound, the pharmaceutically acceptable salt, the ester or the stereoisomer thereof in the manufacture of a medicament for treating and / or preventing KHK mediated diseases and related conditions.
Need to check novelty before this filing date? Find Prior Art
